Jun 24, 2008
Amylin Has Yet to Crack Tough Diabetes Market
Diabetes is a tough market to compete in for any company. Insulin is the standard therapy for most patients with severe Diabetes.
Comments
Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.
| Topic | Updated | Last By | Comments |
|---|---|---|---|
| Lilly, Amylin Report Four More People Using Dia... | Sep 19 | IN PAIN SALI... | 2 |
| Byetta Diabetes Drug Side Effects linked to Pan... | Sep 16 | alan reid | 1 |
| Eli Lilly reports new Byetta deaths | Sep '08 | edd | 4 |
| FDA reports new deaths with diabetes drug Byetta | Aug '08 | Danny Haszard | 2 |
| New warning on diabetes drug | Aug '08 | GAR19 | 1 |
| FDA reports deaths with diabetes drug Byetta | Aug '08 | lchelps | 2 |
| FDA reports new deaths with diabetes drug | Aug '08 | not brainwas... | 1 |
